0 50

Cited 0 times in

Effect of drug compliance on health care costs in newly-diagnosed dementia: Analysis of nationwide population-based data

 Seung-Taek Oh  ;  Kyu-Tae Han  ;  Won-Jung Choi  ;  Jaesub Park 
 JOURNAL OF PSYCHIATRIC RESEARCH, Vol.118 : 31-37, 2019-11 
Journal Title
Issue Date
Aged ; Aged, 80 and over ; Cholinesterase Inhibitors / therapeutic use* ; Dementia / drug therapy* ; Female ; Health Care Costs / statistics & numerical data* ; Health Expenditures / statistics & numerical data* ; Humans ; Male ; Medication Adherence / statistics & numerical data* ; National Health Programs / statistics & numerical data* ; Nootropic Agents / therapeutic use* ; Republic of Korea ; Retrospective Studies
Background: The cost-effectiveness of both cholinesterase inhibitors and memantine by delaying nursing home placement has been supported by numerous studies. The importance of sustained pharmacological treatment in dementia has been relatively less recognized by public health policies compared to early diagnosis. We investigated the effect of the drug (donepezil, rivastigmine, galantamine, and memantine) compliance on the health care costs in newly-diagnosed dementia. Methods: National Health Insurance Service (NHIS) database which covers the entire population of South Korea was used for analysis. Health care expenditure of patients newly-diagnosed with dementia in between 2012 and 2014 was investigated for 3-5 years. For drug compliance, we used Medication Possession Ratio (MPR) that indicates the percentage of time a patient has access to medication. Multivariate linear regression analysis including generalized estimated equation and gamma distribution was used for statistical analysis. Results: We identified 252,594 patients who were both prescribed with cognitive enhancers and newly diagnosed with dementia. When initial MPR increased 20%, total health care costs decreased 8.4% (RR = 0.916, 95%; CI 0.914 to 0.916). Same relationship was shown with medical costs related to dementia, admission to a general hospital, and emergency room visits. When MPR increased 20% compared to the previous year, the total health care costs, admission to a general hospital, emergency room visits, and admission to a nursing hospital decreased. Conclusions: This population-based retrospective cohort study provides evidence that patients newly-diagnosed with dementia who showed higher initial drug compliance or maintained antidementia drugs (Cholinesterase inhibitors and memantine) would benefit in total health-care costs.
Full Text
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Psychiatry (정신과학교실) > 1. Journal Papers
Yonsei Authors
Park, Jaesub(박재섭)
사서에게 알리기


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.